CStone Pharmaceuticals is a biopharmaceutical company based in Suzhou, China, that discovers, develops and commercialises medicines for cancer and other serious diseases. Its work centres on immuno-oncology and precision therapies, including antibody treatments and targeted drugs for tumours such as lung cancer and certain blood cancers. The company serves patients and healthcare providers in China and works with international partners to develop and bring its product candidates to market.
On this site CStone Pharmaceuticals appears as a stock on the Hong Kong Stock Exchange (Hong Kong), code 2616, with prices in Hong Kong dollars (HKD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Weak price profile
Ranks #1605 of 2611 on the Hong Kong Stock Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for Hong Kong yet.
TrendWeak
34/100
Below its long-term averages and far from its highs.
See the numbers →
Above 200-day average-24.4%
From 52-week high-54.1%
MomentumWeak
40/100
Lagging most stocks on this exchange.
See the numbers →
3-month return-0.8%
6-month return-53.7%
12-month, skipping last month-16.6%
Stability (higher is calmer)Weak
29/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)78.8%
Worst drawdown, 1 year (smaller is calmer)-59.0%
LiquidityStrong
87/100
Trades actively.
See the numbers →
Avg daily value traded52.51M HKD
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for Hong Kong when fundamentals data for this market is added. All Hong Kong stocks.
52-wk range 4.010 – 10.410Daily closes, split-adjusted
Signals
50-day average5.580
200-day average6.213
Golden/death cross (60d)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.350
Technical summary
Daily
Strongly bearish
3 bullish · 1 neutral · 12 bearish
Weekly
Strongly bearish
2 bullish · 1 neutral · 9 bearish
Monthly
Bearish
2 bullish · 1 neutral · 5 bearish
Moving averages (daily)
SMA 10
4.96
Bearish
EMA 10
5.02
Bearish
SMA 20
5.28
Bearish
EMA 20
5.20
Bearish
SMA 50
5.58
Bearish
EMA 50
5.40
Bearish
SMA 100
5.20
Bearish
EMA 100
5.64
Bearish
SMA 200
6.21
Bearish
EMA 200
5.88
Bearish
Oscillators (daily)
RSI (14)
38.00
Neutral
MACD (12, 26)
-0.21
Bearish
Momentum (12)
-17.11
Bearish
Stochastic %K (14)
5.81
Bullish
Williams %R (14)
-94.19
Bullish
CCI (20)
-102.7
Bullish
Pivot points (classic, last session)
S3
4.05
S2
4.34
S1
4.52
Pivot
4.81
R1
4.99
R2
5.28
R3
5.46
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in HKD. Educational only, not financial advice.
